ACAM1000 + vaccinia virus (calf lymph) smallpox vaccine: Dryvax
Phase 2Terminated 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smallpox
Conditions
Smallpox
Trial Timeline
Sep 1, 2002 → Sep 1, 2003
NCT ID
NCT00053508About ACAM1000 + vaccinia virus (calf lymph) smallpox vaccine: Dryvax
ACAM1000 + vaccinia virus (calf lymph) smallpox vaccine: Dryvax is a phase 2 stage product being developed by Sanofi for Smallpox. The current trial status is terminated. This product is registered under clinical trial identifier NCT00053508. Target conditions include Smallpox.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00053508 | Phase 2 | Terminated |
Competing Products
20 competing products in Smallpox
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Smallpox vaccine, LISTER strain, from chick embryo cells | Sanofi | Phase 2 | 51 |
| MVA (smallpox vaccine) | Sanofi | Phase 1 | 32 |
| ACAM3000 MVA Vaccine | Sanofi | Phase 1 | 32 |
| MVA Smallpox vaccine + Placebo | Sanofi | Phase 2 | 51 |
| IMVAMUNE (MVA-BN) | Bavarian Nordic | Phase 2 | 49 |
| MVA-BN | Bavarian Nordic | Phase 1 | 30 |
| IMVAMUNE® | Bavarian Nordic | Phase 2 | 49 |
| LF formulation of IMVAMUNE® + FD formulation of IMVAMUNE® | Bavarian Nordic | Phase 2 | 49 |
| IMVAMUNE + IMVAMUNE | Bavarian Nordic | Phase 2 | 49 |
| FD MVA-BN | Bavarian Nordic | Phase 3 | 74 |
| IMVAMUNE® | Bavarian Nordic | Phase 3 | 74 |
| IMVAMUNE + IMVAMUNE | Bavarian Nordic | Phase 2 | 49 |
| MVA-BN® (IMVAMUNE) + Placebo | Bavarian Nordic | Phase 2 | 49 |
| Elstree-BN | Bavarian Nordic | Phase 1 | 30 |
| ACAM2000 | Emergent BioSolutions | Phase 3 | 69 |
| VIGIV | Emergent BioSolutions | Pre-clinical | 15 |
| ACAM2000® smallpox vaccine | Emergent BioSolutions | Pre-clinical | 15 |
| Brincidofovir | Emergent BioSolutions | Phase 1 | 25 |
| Vaccination with ACAM2000 | Emergent BioSolutions | Approved | 77 |
| ACAM2000 Smallpox Vaccine + Vaccinia virus (calf lymph) smallpox vaccine: Dryvax® | Emergent BioSolutions | Phase 2 | 44 |